Thomas E. Keane

6.2k total citations · 2 hit papers
126 papers, 4.3k citations indexed

About

Thomas E. Keane is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Thomas E. Keane has authored 126 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Pulmonary and Respiratory Medicine, 47 papers in Surgery and 28 papers in Molecular Biology. Recurrent topics in Thomas E. Keane's work include Prostate Cancer Treatment and Research (36 papers), Prostate Cancer Diagnosis and Treatment (30 papers) and Bladder and Urothelial Cancer Treatments (23 papers). Thomas E. Keane is often cited by papers focused on Prostate Cancer Treatment and Research (36 papers), Prostate Cancer Diagnosis and Treatment (30 papers) and Bladder and Urothelial Cancer Treatments (23 papers). Thomas E. Keane collaborates with scholars based in United States, United Kingdom and Canada. Thomas E. Keane's co-authors include Laurence Klotz, A. Bono, Walter Albrecht, Richard Sylvester, Hendrik Van Poppel, L. Da Pozzo, Vsevolod Matveev, Eila C. Skinner, Jean-Marie Maréchal and Sandra Collette and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Gastroenterology.

In The Last Decade

Thomas E. Keane

125 papers receiving 4.3k citations

Hit Papers

A Prospective Randomized EORTC Intergroup Phase 3 Study C... 2006 2026 2012 2019 2006 2010 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A Prospective Randomized EORTC Intergroup Phase 3 Study Comparing the Complications of Elective Nephron-Sparing Surgery and Radical Nephrectomy for Low-Stage Renal Cell Carcinoma
    2006 764 citations Thomas E. Keane et al. European Urology profile →
  2. A Prospective, Randomised EORTC Intergroup Phase 3 Study Comparing the Oncologic Outcome of Elective Nephron-Sparing Surgery and Radical Nephrectomy for Low-Stage Renal Cell Carcinoma
    2010 698 citations Thomas E. Keane et al. European Urology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas E. Keane United States 33 2.5k 1.8k 1.3k 718 402 126 4.3k
John A. Libertino United States 40 2.4k 1.0× 1.5k 0.9× 1.8k 1.3× 518 0.7× 638 1.6× 184 4.7k
C.C. Abbou France 40 2.5k 1.0× 2.0k 1.1× 2.3k 1.7× 678 0.9× 684 1.7× 139 5.0k
William A. See United States 34 1.6k 0.7× 621 0.3× 1.7k 1.3× 599 0.8× 356 0.9× 179 3.8k
Ricardo Rendon Canada 30 2.1k 0.8× 1.3k 0.7× 1.4k 1.1× 542 0.8× 333 0.8× 193 3.4k
Vincent Molinié France 33 2.3k 0.9× 1.9k 1.1× 1.0k 0.8× 609 0.8× 949 2.4× 166 4.1k
Howard Kynaston United Kingdom 32 1.3k 0.5× 1.2k 0.7× 1.2k 0.9× 914 1.3× 601 1.5× 111 4.0k
Dragan Golijanin United States 33 1.5k 0.6× 1.2k 0.6× 1.5k 1.1× 628 0.9× 614 1.5× 110 4.0k
Edouard J. Trabulsi United States 33 2.3k 0.9× 552 0.3× 1.3k 1.0× 841 1.2× 494 1.2× 201 4.0k
Richard Cathomas Switzerland 28 1.3k 0.5× 1.1k 0.6× 2.0k 1.5× 1.5k 2.0× 525 1.3× 149 4.0k
Takefumi Satoh Japan 33 1.6k 0.7× 878 0.5× 546 0.4× 665 0.9× 441 1.1× 157 3.6k

Countries citing papers authored by Thomas E. Keane

Since Specialization
Citations

This map shows the geographic impact of Thomas E. Keane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas E. Keane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas E. Keane more than expected).

Fields of papers citing papers by Thomas E. Keane

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas E. Keane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas E. Keane. The network helps show where Thomas E. Keane may publish in the future.

Co-authorship network of co-authors of Thomas E. Keane

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas E. Keane. A scholar is included among the top collaborators of Thomas E. Keane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas E. Keane. Thomas E. Keane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Crawford, E. David, Jason Hafron, Scott T. Tagawa, et al.. (2020). Impact of Late Dosing on Testosterone Suppression with 2 Different Leuprolide Acetate Formulations: In Situ Gel and Microsphere. An Analysis of United States Clinical Data. The Journal of Urology. 205(2). 554–560. 5 indexed citations
2.
Coté, Gregory A., E Förster, Robert A. Moran, et al.. (2020). Comparison of Urologist- vs Gastroenterologist-Directed Extracorporeal Shock Wave Lithotripsy for Pancreaticolithiasis. Clinical Gastroenterology and Hepatology. 19(6). 1234–1239. 3 indexed citations
3.
Shore, Neal D., Michael A. O’Donnell, Thomas E. Keane, et al.. (2020). PD03-02 PHASE 3 RESULTS OF VICINIUM IN BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER. The Journal of Urology. 203(Supplement 4). 26 indexed citations
4.
Evans, Christopher P., Celestia S. Higano, Thomas E. Keane, et al.. (2016). The PREVAIL Study: Primary Outcomes by Site and Extent of Baseline Disease for Enzalutamide-treated Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer. European Urology. 70(4). 675–683. 66 indexed citations
5.
6.
Li, Chunyu, Steven B. Zeliadt, Ingrid J. Hall, et al.. (2013). Burden among partner caregivers of patients diagnosed with localized prostate cancer within 1 year after diagnosis: an economic perspective. Supportive Care in Cancer. 21(12). 3461–3469. 40 indexed citations
7.
Ramsey, Scott D., Steven B. Zeliadt, David K. Blough, et al.. (2013). Impact of Prostate Cancer on Sexual Relationships: A Longitudinal Perspective on Intimate Partners' Experiences. The Journal of Sexual Medicine. 10(12). 3135–3143. 46 indexed citations
8.
Chaudhary, Uzair B., Nitin Verma, Thomas E. Keane, & Vinay Gudena. (2012). A Phase II Study of Gemcitabine and Irinotecan in Patients With Locally Advanced or Metastatic Bladder Cancer. American Journal of Clinical Oncology. 37(2). 188–193. 9 indexed citations
9.
Schröder, Fritz H., et al.. (2012). Androgen deprivation therapy: past, present and future. British Journal of Urology. 109(s6). 1–12. 86 indexed citations
10.
11.
Keane, Thomas E., David Gillatt, C.A. Lawton, Heather Payne, & Bertrand Tombal. (2007). Treatment Options in Prostate Cancer Once Primary Therapy Fails. European Urology Supplements. 6(3). 344–353. 3 indexed citations
12.
Guerrero, Marlon A., et al.. (2007). Inferior vena cava reconstruction using fresh inferior vena cava allograft following caval resection for leiomyosarcoma: Midterm results. Journal of Vascular Surgery. 46(1). 140–143. 26 indexed citations
13.
Fleshner, Neil, et al.. (2007). Adjuvant androgen deprivation therapy augments cure and long-term cancer control in men with poor prognosis, nonmetastatic prostate cancer. Prostate Cancer and Prostatic Diseases. 11(1). 46–52. 10 indexed citations
14.
Liu, Xiang, Saeed Elojeimy, Ahmed El‐Zawahry, et al.. (2006). Modulation of Ceramide Metabolism Enhances Viral Protein Apoptin's Cytotoxicity in Prostate Cancer. Molecular Therapy. 14(5). 637–646. 50 indexed citations
15.
Keane, Thomas E., et al.. (2005). Partial segmental thrombosis of corpus cavernosum: Case report and review of world literature. Urology. 66(1). 194–194. 36 indexed citations
16.
El-Galley, Rizk, Thomas E. Keane, & Carrie Sun. (2003). Camptothecin analogues and vinblastine in the treatment of renal cell carcinoma: an in vivo study using a human orthotopic renal cancer xenograft. Urologic Oncology Seminars and Original Investigations. 21(1). 49–57. 13 indexed citations
17.
El-Galley, Rizk & Thomas E. Keane. (2000). EMBRYOLOGY, ANATOMY, AND SURGICAL APPLICATIONS OF THE KIDNEY AND URETER. Surgical Clinics of North America. 80(1). 381–401. 29 indexed citations
18.
Jiménez, Rafael E., et al.. (2000). pT1 Urothelial Carcinoma of the Bladder: Criteria for Diagnosis, Pitfalls, and Clinical Implications. Advances in Anatomic Pathology. 7(1). 13–25. 34 indexed citations
19.
Keane, Thomas E. & Sam D. Graham. (1995). Conservative Renal Surgery. Surgical Oncology Clinics of North America. 4(2). 295–306. 2 indexed citations
20.
Keating, W. Dennis & Thomas E. Keane. (1989). Irish industrial structure, 1979-1985: a longitudinal analysis. Arrow@dit (Dublin Institute of Technology). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John A. Libertino Breakdown of academic impact, for papers by C.C. Abbou Breakdown of academic impact, for papers by William A. See Breakdown of academic impact, for papers by Ricardo Rendon Breakdown of academic impact, for papers by Vincent Molinié Breakdown of academic impact, for papers by Howard Kynaston Breakdown of academic impact, for papers by Dragan Golijanin Breakdown of academic impact, for papers by Edouard J. Trabulsi Breakdown of academic impact, for papers by Richard Cathomas Breakdown of academic impact, for papers by Takefumi Satoh
Rankless by CCL
2026